Anti-hypertensive treatment prolongs tPA door-to-treatment time: Secondary analysis of the INSTINCT trial.

BACKGROUND/PURPOSE: Identifying modifiable tPA treatment delays may improve stroke outcomes. We hypothesized that pre-thrombolytic anti-hypertensive treatment (AHT) may prolong door-to-treatment time (DTT). METHODS: Analysis of consecutive tPA-treated patients at 24 randomly selected community hospi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Skolarus, Lesli E., Scott, Phillip A., Burke, James F., Adelman, Eric E., Frederiksen, Shirley M., Kade, Allison M., Kalbfleisch, Jack D., Ford, Andria L., Meurer, William J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508250/
https://ncbi.nlm.nih.gov/pubmed/23033348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.112.662684
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak